USPTO Biotech/Chemical Partnership (BCP) Meetings

Jan 28, 2020, 17:18 PM by AIPLA Admin

All stakeholders are invited to the USPTO's Biotechnology, Chemical and Pharmaceutical Partnership (BCP) Meeting to share insights and experiences to improve patent prosecution in these areas. The meeting will be held at the USPTO headquarters in Alexandria, Virginia, and online. Participants will be able to speak with agency experts either in person or via webcast from all locations.

Tuesday, January 28, 2020

10:30 a.m. to 5 p.m. ET

United States Patent and Trademark Office
USPTO Alexandria Campus, Clara Barton Auditorium, South

Topics
•    Subject matter eligibility (35 U.S.C. §101) guidance update
•    Restriction Practice
•    Patent term adjustment
•    Orange Book and biologic patent study
•    Written Description for Living Inventions


10:30 – 10:40 a.m. Welcoming and opening remarks

• Gary Jones Director, TC1600, USPTO
• Andrew Wang Director, TC1600, USPTO
• Karl Skowronek Director (Acting), TC1600, USPTO

10:40 – 11:20 a.m. Restriction practice

• Janet Andres SPE, TC1600, USPTO

11:20 – 12:00 p.m. Orange Book and biologic patent study

• Michelle Ankenbrand Lead Administrative Patent Judge, PTAB, USPTO
• Jason Repko Administrative Patent Judge, PTAB, USPTO

12:00 – 1:00 p.m. Lunch/Networking

1:00 – 1:50 p.m. Patent term adjustment

• Kery Fries Senior Legal Advisor, OPLA, USPTO

1:50 – 2:50 p.m. Satisfying the written description requirement for living inventions

• Bethany Reid Roahrig Patent Agent, Setter Roche LLP

2:50 – 3:00 p.m. Break

3:00 – 4:00 p.m. Subject matter eligibility (101) update

• June Cohan, Senior Legal Advisor, OPLA
• Daniel Kolker, SPE, TC1600
• Zachariah Lucas, QAS, TC1600, USPTO

4:00 – 4:10 p.m. Closing remarks

• TC directors